Header Logo

Connection

SANJAY MATHEW to Interleukin-6

Back to Details
This is a "connection" page, showing publications SANJAY MATHEW has written about Interleukin-6.
SANJAY MATHEW
Connection Strength
0.050
Interleukin-6
  1. Lack of relationships between ketamine treatment and peripheral neurotrophic and inflammatory factors in a randomized controlled ketamine trial of major depressive disorder. Brain Behav Immun. 2025 Aug; 128:170-178.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.